异基因骨髓联合造血干细胞移植术治疗恶性血液病12例(3)
 |
| 第1页 |
参见附件。
[8] 陈育红,黄晓军,郭乃榄,等.异基因造血于细胞移植后急性移植物抗宿主病的发生及其危险因素的探讨[J].中华血液学杂志,2003,24;61
[9] Lu DP,Dong L,Wu T,et al.Conditioning including antithymocyte globulin followed by unmanipulated HLA—mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA—identical sibling transplantation.Blood,2006,107(8):3065-3073
[10] 梁辉,陈琳军,马静秋,等.ATG用于异体造血千细胞移植前预防移植物抗宿主反应[J].上海交通大学学报,2007,27(8):1011-1013
[11] Champlin R,Schmitz N,Mary M,et a1.Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation[J].Blood,2000,95;3702-3709
[12] Lazarus HM,Koc ON,Devine SM,et a1.Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients[J].J Biol Blood Marrow Transplantation,2005,ll(5):389-398
[13] Morton J,Hutchine C,Durrant.Granulocyte—colony—stimulating factor(G—C SF)一primed allogeneic bone marrow:significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cell[J].Blood,2001,98;3186-3191
[14] 李庆山,毛平,王顺青,等.骨髓联合外周造血下细胞移植治疗重型再生障碍性贫血[J].广东医学,24(11):1209-1211
您现在查看是摘要介绍页，详见PDF附件(2249kb)。